DOES SEROPOSITIVITY INFLUENCE DIFFERENTIALLY DRUG DISCONTINUATION OF BIOLOGIC ANTIRHEUMATIC AGENTS WITH NON-ANTI-TNF MODE OF ACTION?

Author(s):
Finckh, A.; Courvoisier, D.; Gottenberg, J.E.; Marlette, X.; Morel, J.; Bergstra, S.A. (0000-0002-7136-5248); Hernandez, V.; Codreanu, C.; Kviens, T.K.; Santos, M.J.; Pavelka, K.; Hetland, M.; Chatzidionysiou, K.; Askling, J.; Turesson, C.; Gabay, C.; Vollenhoven, R. van
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-06-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2017), Vol. 76, p. 567-567
hdl
1887/115760
doi
10.1136/annrheumdis-2017-eular.6006